Strides Arcolab is currently trading at Rs 675.95, up by 7.00 points or 1.05% from its previous closing of Rs. 668.95 on the BSE.
The scrip opened at Rs 672.00 and has touched a high and low of Rs 689.00 and Rs 656.50 respectively. So far 155469 shares were traded on the counter.
The BSE group 'A' stock of face value Rs 10 has touched a 52 week high of Rs 1050.00 on 05-Dec-2013 and a 52 week low of Rs 343.80 on 26-Feb-2014.
Last one week high and low of the scrip stood at Rs 696.00 and Rs 651.40 respectively. The current market cap of the company is Rs 4014.72 crore.
The promoters holding in the company stood at 27.67% while Institutions and Non-Institutions held 50.73% and 21.59% respectively.
Strides Arcolab has reported results for first quarter ended June 30, 2014.
The company’s net profit jumped over 12 fold at Rs 26.80 crore as compared to Rs 2.16 crore for the quarter ended June 30, 2013. The company’s total income has surged by 22.95% to Rs 226.28 crore for the quarter under review from Rs 184.04 crore for the corresponding quarter of the previous year.
Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1502.30 |
Dr. Reddys Lab | 6198.90 |
Cipla | 1402.20 |
Zydus Lifesciences | 957.00 |
Lupin | 1645.00 |
View more.. |